Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-EN | Version v3-FR | |
---|---|---|
Language | English | French |
Date Updated | 2024-02-10 | 2024-01-12 |
Drug Identification Number | 02417030 | 02417030 |
Brand name | BEXSERO | BEXSERO |
Common or Proper name | Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) | Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) |
Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
Ingredients | OUTER MEMBRANE VESICLES RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN | OUTER MEMBRANE VESICLES RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN |
Strength(s) | 25MCG 50MCG 50MCG 50MCG | 25MCG 50MCG 50MCG 50MCG |
Dosage form(s) | SUSPENSION | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10s | 10s |
ATC code | J07AH | J07AH |
ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | ||
Actual start date | 2024-01-10 | 2024-01-10 |
Estimated end date | 2024-02-16 | 2024-02-16 |
Actual end date | 2024-02-09 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | Supply available for public programs. Supply unavailable in the private market. Available in packs of 1. | Supply available for public programs. Supply unavailable in the private market. Available in packs of 1. |
Health Canada comments |